Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down’s Syndrome Using Cell Free Fetal DNA in the UK National Health Service

BACKGROUND: Non-invasive prenatal testing (NIPT) for Down’s syndrome (DS) using cell free fetal DNA in maternal blood has the potential to dramatically alter the way prenatal screening and diagnosis is delivered. Before NIPT can be implemented into routine practice, information is required on its co...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Stephen, Karlsen, Saffron, Chung, Nancy, Hill, Melissa, Chitty, Lyn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979704/
https://www.ncbi.nlm.nih.gov/pubmed/24714162
http://dx.doi.org/10.1371/journal.pone.0093559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979704/
https://www.ncbi.nlm.nih.gov/pubmed/24714162
http://dx.doi.org/10.1371/journal.pone.0093559

Ejemplares similares